BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20241205T150000
DTEND;TZID=Europe/Paris:20241205T160000
DTSTAMP:20260421T200256
CREATED:20241028T112147Z
LAST-MODIFIED:20241105T163032Z
UID:329821-1733410800-1733414400@www.afssi.fr
SUMMARY:Webinaire Atlanchim Pharma - Reduction of azides to primary amines
DESCRIPTION:Webinaire Atlanchim Pharma  – Reducution of azides to primary amines InscriptionInscription\n  \n \n\n\n\n\n\n\nJacques LEBQRETON \nScientific Director\, Atlanchim Pharma \n \n \n \n\n\n\n\n\nHis current research activity concerns the synthesis of biologically active molecules\, natural or not\, in the fields of cancer\, viral pathologies and neurodegenerative diseases\, through academic and industrial collaborations. He is also strongly involved in the understanding of biological mechanisms through the synthesis of molecules selectively labeled by non-radioactive isotopes. \nMember of the scientific committee of the European Journal of Organic Chemistry (2004-14)\, Current Organic Synthesis (2004-2018) and Molecules\, Medicinal Chemistry Section (2020- ). \nMember of the National Scientific Research Committee (CNRS – section 12) (2012-2016 and 2017-2022) and member of HCERES (Haut Conseil de l’évaluation de la recherche et de l’enseignement supérieur – ST4) (2022-2026). \nFounding partner of the CRO AtlanchimPharma (custom fine chemistry and synthesis of stable isotope labeled molecules) and consultant (since 2004). Professor at the University of Nantes (CEISAM\, UMR-CNRS 6513 – Symbiosis group (Multi-step synthesis and bioscience)) Co-author of about 190 publications (h-index 36) and 18 patents (including two with exploitation license and one know-how license)\, and more than 120 seminars and conferences. \nDiscover the program of this webinar :\nOrganic azides are versatile nitrogen intermediates in organic chemistry and biochemistry\, and their transformation into amines provides a broad scope of applications. In this new AtlanChim Pharma webinar\, we will illustrate the most significant methodologies described in recent work for reducing azides to the corresponding amines\, through recent examples from medicinal chemistry and total synthesis of natural products. While azide hydrogenation and the Staudinger reaction are widely used\, we will also focus on less conventional methodologies. \n  \nInscription\n  \n 
URL:https://www.afssi.fr/event/webinaire-atlanchim-pharma-reduction-of-azides-to-primary-aminrd/
LOCATION:Format digital
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/png:https://www.afssi.fr/wp-content/uploads/2024/10/PNG-Banniere-Webinaire-AtlanChim-122024.png
END:VEVENT
END:VCALENDAR